(Q52529596)
Statements
Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production (English)
F J Dumont
M J Staruch
P Fischer
C DaSilva